The principal ability to deliver a cytotoxic agent to cancer cells is shown by the example of recombinant miniantibodies specific to HER2 and fused with barstar, and a visualizing component—the recombinant fluorescent protein EGFP fused with barnase [61]. This evidence concerns the gene ERBB2 and cancer.